YANG Xiao-li. Clinical study of the treatment of metastatic breast cancer mainly by paclitaxol combined with chemotherapy[J]. Chinese Journal of Modern Applied Pharmacy, 2006, (8): 804-806.
Citation:
YANG Xiao-li. Clinical study of the treatment of metastatic breast cancer mainly by paclitaxol combined with chemotherapy[J]. Chinese Journal of Modern Applied Pharmacy, 2006, (8): 804-806.
YANG Xiao-li. Clinical study of the treatment of metastatic breast cancer mainly by paclitaxol combined with chemotherapy[J]. Chinese Journal of Modern Applied Pharmacy, 2006, (8): 804-806.
Citation:
YANG Xiao-li. Clinical study of the treatment of metastatic breast cancer mainly by paclitaxol combined with chemotherapy[J]. Chinese Journal of Modern Applied Pharmacy, 2006, (8): 804-806.
Clinical study of the treatment of metastatic breast cancer mainly by paclitaxol combined with chemotherapy
OBJECTIVE To study the efficacy and toxicity of paclitaxol combined different chemotherapy in treatment of metastatic breast cancer.METHODS Paclitaxol 150mg/m2 iv drop on day 1;DDP 50mg/m2 iv drop for day 2 and 3;VP16 60mg/m2 iv drop for day 1 and 3;or EP